2-215312084-T-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_004044.7(ATIC):​c.-59T>G variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.295 in 1,528,280 control chromosomes in the GnomAD database, including 70,884 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.23 ( 5130 hom., cov: 34)
Exomes 𝑓: 0.30 ( 65754 hom. )

Consequence

ATIC
NM_004044.7 5_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.144
Variant links:
Genes affected
ATIC (HGNC:794): (5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase) This gene encodes a bifunctional protein that catalyzes the last two steps of the de novo purine biosynthetic pathway. The N-terminal domain has phosphoribosylaminoimidazolecarboxamide formyltransferase activity, and the C-terminal domain has IMP cyclohydrolase activity. A mutation in this gene results in AICA-ribosiduria. [provided by RefSeq, Sep 2009]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BP6
Variant 2-215312084-T-G is Benign according to our data. Variant chr2-215312084-T-G is described in ClinVar as [Benign]. Clinvar id is 1192366.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.439 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ATICNM_004044.7 linkc.-59T>G 5_prime_UTR_variant Exon 1 of 16 ENST00000236959.14 NP_004035.2 P31939-1V9HWH7

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ATICENST00000236959.14 linkc.-59T>G 5_prime_UTR_variant Exon 1 of 16 1 NM_004044.7 ENSP00000236959.9 P31939-1

Frequencies

GnomAD3 genomes
AF:
0.233
AC:
35377
AN:
152100
Hom.:
5126
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.0559
Gnomad AMI
AF:
0.327
Gnomad AMR
AF:
0.282
Gnomad ASJ
AF:
0.319
Gnomad EAS
AF:
0.220
Gnomad SAS
AF:
0.454
Gnomad FIN
AF:
0.270
Gnomad MID
AF:
0.332
Gnomad NFE
AF:
0.302
Gnomad OTH
AF:
0.248
GnomAD4 exome
AF:
0.302
AC:
415869
AN:
1376064
Hom.:
65754
Cov.:
33
AF XY:
0.308
AC XY:
209190
AN XY:
679094
show subpopulations
African (AFR)
AF:
0.0447
AC:
1375
AN:
30744
American (AMR)
AF:
0.304
AC:
10743
AN:
35316
Ashkenazi Jewish (ASJ)
AF:
0.312
AC:
7782
AN:
24910
East Asian (EAS)
AF:
0.172
AC:
6069
AN:
35208
South Asian (SAS)
AF:
0.459
AC:
35934
AN:
78222
European-Finnish (FIN)
AF:
0.277
AC:
9517
AN:
34300
Middle Eastern (MID)
AF:
0.308
AC:
1301
AN:
4228
European-Non Finnish (NFE)
AF:
0.303
AC:
325643
AN:
1075668
Other (OTH)
AF:
0.305
AC:
17505
AN:
57468
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
14191
28383
42574
56766
70957
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10792
21584
32376
43168
53960
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.233
AC:
35393
AN:
152216
Hom.:
5130
Cov.:
34
AF XY:
0.235
AC XY:
17469
AN XY:
74440
show subpopulations
African (AFR)
AF:
0.0557
AC:
2318
AN:
41580
American (AMR)
AF:
0.282
AC:
4310
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.319
AC:
1109
AN:
3472
East Asian (EAS)
AF:
0.220
AC:
1137
AN:
5174
South Asian (SAS)
AF:
0.455
AC:
2197
AN:
4826
European-Finnish (FIN)
AF:
0.270
AC:
2859
AN:
10588
Middle Eastern (MID)
AF:
0.316
AC:
93
AN:
294
European-Non Finnish (NFE)
AF:
0.302
AC:
20539
AN:
67970
Other (OTH)
AF:
0.252
AC:
533
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1368
2736
4103
5471
6839
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
392
784
1176
1568
1960
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.145
Hom.:
295
Bravo
AF:
0.224
Asia WGS
AF:
0.368
AC:
1278
AN:
3474

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

AICA-ribosiduria Benign:1
Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.79
CADD
Benign
4.9
DANN
Benign
0.58
PhyloP100
-0.14
PromoterAI
0.44
Neutral
Mutation Taster
=300/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4535042; hg19: chr2-216176807; API